GlassScriptPhysician profile
Carlos Picone
NPI 1861475840
$74,357.20
in general payments reported to CMS, 2019-2025
54 companies · $3,599 in 2025
The $3,599 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28K · 2020: $9,689 · 2021: $9,891 · 2022: $10K · 2023: $9,053 · 2024: $4,350 · 2025: $3,599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $4,366 · Education: $270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,365.97 |
| Consulting Fee | $4,366.00 |
| Education | $269.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insmed, INC. | $32,504.29 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $19,549.48 | 2019-2024 | Yupelri, Yupelri |
| Astrazeneca Pharmaceuticals LP | $7,075.51 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $3,989.71 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $1,987.03 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,221.03 | 2019-2025 | Ofev |
| Grifols USA, LLC | $1,046.83 | 2019-2025 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $788.06 | 2020-2024 | Acthar |
| Bayer Healthcare Pharmaceuticals INC. | $711.32 | 2019-2025 | |
| Actelion Pharmaceuticals US, INC. | $703.51 | 2019-2025 | Opsumit, Uptravi |
| Amgen INC. | $509.91 | 2019-2025 | Tezspire |
| United Therapeutics Corporation | $442.94 | 2020-2025 | Tyvaso, Tyvaso |
| Genentech USA, INC. | $420.00 | 2019-2022 | |
| Electromed, INC. | $323.66 | 2019-2025 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $296.57 | 2019-2025 | Dupixent |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $189.94 | 2024-2025 | |
| Pfizer INC. | $180.99 | 2019-2025 | |
| Viatris Specialty LLC | $153.55 | 2025 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $153.00 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $151.24 | 2022 | |
| Shionogi INC | $142.03 | 2022-2024 | Fetroja |
| Axsome Therapeutics, INC. | $133.19 | 2023-2025 | Sunosi |
| Merck Sharp & Dohme LLC | $118.81 | 2019-2024 | Zerbaxa, Dificid |
| Baxter Healthcare | $110.91 | 2022-2024 | Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $109.69 | 2021-2025 | |
| Inspire Medical Systems, INC. | $85.93 | 2023-2025 | Inspire |
| Lilly USA, LLC | $83.66 | 2022-2025 | Zepbound, Mounjaro |
| Janssen Pharmaceuticals, INC | $82.34 | 2019-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $77.12 | 2020-2023 | Cuvitru |
| Verona Pharma, INC. | $75.30 | 2025 | Ohtuvayre |
| Gilead Sciences, INC. | $75.17 | 2019-2025 | Veklury |
| Astellas Pharma US INC | $66.26 | 2021-2024 | Cresemba |
| Sunovion Pharmaceuticals INC. | $64.84 | 2019 | |
| Inogen, INC. | $61.83 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Ani Pharmaceuticals, INC. | $58.26 | 2024 | Purified Cortrophin Gel |
| Mallinckrodt Enterprises LLC | $54.16 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $52.92 | 2020-2022 | |
| Medivance, INC. | $50.26 | 2020 | |
| Abbvie INC. | $46.51 | 2021 | |
| Idorsia Pharmaceuticals US INC | $45.73 | 2022-2023 | Quviviq |
| Novo Nordisk INC | $45.30 | 2020-2023 | Rybelsus, Ozempic |
| Exact Sciences Corporation | $45.20 | 2023-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $41.27 | 2019-2023 | |
| Daiichi Sankyo INC. | $41.21 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $27.34 | 2022-2024 | Ryaltris |
| Philips North America LLC | $26.26 | 2022 | |
| Harmony Biosciences LLC | $23.15 | 2025 | |
| Pulmonx Corporation | $22.44 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Ambu INC. | $19.95 | 2022 | |
| Shire North American Group INC | $19.77 | 2019 | |
| Vifor Pharma, INC. | $19.70 | 2024 | Zemaira |
| Nabriva Therapeutics, Plc | $16.29 | 2020 | |
| Allergan, INC. | $15.83 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Picone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.